首页> 外文期刊>Clinical infectious diseases >Valuing Influenza Vaccine: Medical, Economic, and Social Benefits
【24h】

Valuing Influenza Vaccine: Medical, Economic, and Social Benefits

机译:重视流感疫苗:医疗,经济和社会效益

获取原文
获取原文并翻译 | 示例
           

摘要

Every year, an influenza epidemic occurs that results in substantial global mortality and morbidity, as well as significant economic costs. The Centers for Disease Control and Prevention estimates that a mean of 200,000 excess hospitalizations occur and 36,000 Americans die every year because of influenza and its complications; therefore, influenza kills more Americans than does .any other vaccine-preventable disease . A mean of 1 in 8300 Americans will die of influenza and its complications by the end of the upcoming influenza season. This annual mortality continues despite the availability of influenza vaccines in the United States since the 1940s. Nearly 70 years later, the public and some health care workers still have questions regarding influenza vaccine safety, efficacy, effectiveness, and cost-effectiveness of vaccination of adults, even though multiple studies and a review of the influenza vaccine data for healthy adults have convincingly revealed that vaccination is effective in preventing influenza virus infection#
机译:每年,流行性感冒都会导致全球大量的死亡率和发病率以及巨大的经济成本。疾病控制与预防中心估计,每年平均有20万例因流感及其并发症而导致的额外住院治疗和36,000名美国人死亡。因此,与其他疫苗可预防的疾病相比,流感对美国人的杀害率更高。在即将到来的流感季节结束之前,平均每8300名美国人中就有1人死于流感及其并发症。尽管自1940年代以来在美国已经有了流感疫苗,但这种年死亡率仍在继续。将近70年后,尽管进行了多项研究并对健康成年人的流感疫苗数据进行了令人信服的调查,但公众和一些卫生保健工作者仍然对成年人接种流感疫苗的安全性,有效性,有效性和成本效益存在疑问。发现疫苗接种可有效预防流感病毒感染#

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号